Healthcare
Viking Therapeutics’ VK2735 Demonstrates Promising Weight Loss Results in Phase 1 and Phase 2 Trials
Clinical Data from Oral and Subcutaneous Doses Show Effective Weight Loss and Support Potential for Long-Term Dosing Strategies Viking Therapeutics...
Merck Posts Q3 Earnings Beat on Keytruda Sales Despite Gardasil Struggles in China
Strong Growth in Keytruda Revenue Contrasts with Decline in Gardasil Sales in China Amid Economic and Regulatory Challenges Merck &...
Tharimmune Advances TH104 Clinical Program for Pruritus in PBC With EMA Guidance
Positive EMA Feedback Boosts Momentum for Tharimmune’s Phase 2 Trial in Treating Debilitating Itch Condition in Primary Biliary Cholangitis Tharimmune...
Apogee Therapeutics’ APG777 Demonstrates Promising Longevity in Phase 1 Study, Ahead of Key 2025 Milestones
Nine-Month Follow-Up Data Validates APG777's Extended Half-Life and Safety, as Investors Look to Pipeline Updates and Upcoming Clinical Data In...
Intuitive Surgical Q3 2024 Earnings: Robust Growth Amid Market Challenges
Key Factors to Watch as da Vinci V Expansion Continues Intuitive Surgical (ISRG) has reported strong third-quarter financial results for...
Study Highlights the Life-Saving Potential of Obesity Drugs and Strengthens the Bullish Case for Viking Therapeutics
VKTX’s Innovative Drug Candidates Could Unlock Significant Value for Patients and Investors A recent study has shone new light on...
EXCLUSIVE: Immunocore CEO Bahija Jallal on Breakthroughs in Immunotherapy and Expanding Treatment Horizons
Stoxpo: Immunocore has made strides with KIMMTRAK in treating uveal melanoma. What has contributed to this success? Bahija Jallal: KIMMTRAK...
180 Life Sciences Corp. Enters the iGaming Industry with Blockchain-Enabled Platform
Leveraging blockchain and cryptocurrency technology, 180 Life Sciences aims to revolutionize the online casino market In a strategic move that...
Bright Minds Biosciences Soars 1,400% in Unprecedented Stock Surge
In an unexpected and dramatic move, Bright Minds Biosciences (DRUG) saw its stock skyrocket by an astonishing 1,400% yesterday, despite...
Larimar Therapeutics: Targeting the Root Cause of Friedreich’s Ataxia with Nomlabofusp
Biotech company poised to lead FA treatment with innovative protein replacement therapy Larimar Therapeutics (LRMR) has emerged as a promising...
